Corporate News     05-Jul-22
Biocon Biologics receives EU GMP certificate for new facility in Bengaluru
Biocon announced that its subsidiary, Biocon Biologics has received a EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022.
Previous News
  Biocon consolidated net profit rises 550.59% in the June 2024 quarter
 ( Results - Announcements 09-Aug-24   07:32 )
  Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
 ( Hot Pursuit - 22-Apr-24   11:39 )
  Biocon arm gets USFDA nod for chronic heart failure drug
 ( Hot Pursuit - 02-Sep-24   08:59 )
  Board of Biocon recommends final dividend
 ( Corporate News - 16-May-24   17:54 )
  Biocon Ltd spurts 1.83%, gains for third straight session
 ( Hot Pursuit - 22-Mar-24   13:05 )
  Biocon to hold board meeting
 ( Corporate News - 11-Apr-24   16:18 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
  Biocon gains after subsidiary secures 'Yesafili' entry into Canadian market
 ( Hot Pursuit - 04-Mar-24   11:42 )
  Biocon Ltd eases for fifth straight session
 ( Hot Pursuit - 25-Oct-23   13:35 )
  Biocon to declare Quarterly Result
 ( Corporate News - 10-Oct-23   11:29 )
  Biocon Biologics divests its non-crore branded formulations biz in India
 ( Corporate News - 10-Nov-23   12:06 )
Other Stories
  ITD Cementation India wins order of Rs 1,937 cr
  03-Oct-24   10:35
  NIIT Learning Systems allots 1,666 equity shares under ESOP
  03-Oct-24   10:30
  Ashoka Metcast to discuss results
  03-Oct-24   10:29
  Emerald Finance to declare Quarterly Result
  03-Oct-24   10:29
  Rhetan TMT schedules board meeting
  03-Oct-24   10:29
  Shrenik to table results
  03-Oct-24   10:29
  Universal Arts to declare Quarterly Result
  03-Oct-24   10:28
  Three M Paper Boards to conduct board meeting
  03-Oct-24   10:28
  Arkade Developers to declare Quarterly Result
  03-Oct-24   10:28
  Worth Investment & Trading Company announces board meeting date
  03-Oct-24   10:28
Back Top